Al-Dawaa Medical Servicesالدواء
- Price
- 48.02 SAR
- Fair value
- 45.54 SAR
- Discount to fair value
- −5%
- Mkt cap
- 4.08B
- P/E
- 11.0×
- P/B
- 2.80×
- EV
- 6.13B
- Div yield
- 5.22%
- ROE
- 25.4%
- Net margin
- 5.7%
Current price48.02SAR
Fair value (est., median)45.54SAR
UndervaluedFair valueOvervalued
+5.5% above fair valueTrading close to fair value.
Median ofDCF 99.07DDM 45.54Graham 39.81Residual Income 47.96Earnings Power 39.15
Health Check
62.1
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Rewards
- Strong return on equity (25.4%).
- Attractive, covered dividend (5.22%).
Risks
- Stretched balance sheet / elevated debt.
- Low fair-value confidence — methods disagree or data is thin.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for detailsDemo series
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
Covers 4 years · FY2021–FY2024
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | TTM'26 |
|---|---|---|---|---|---|
| Revenue | 5.03B | 5.37B | 5.74B | 6.45B | — |
| Net Income | 239.14M | 305.45M | 329.22M | 370.11M | 238.84M |
| Net Margin | 4.8% | 5.7% | 5.7% | 5.7% | — |
| Operating Cash Flow | 670.14M | 777.51M | 725.75M | 683.33M | — |
| OCF Margin | 13.3% | 14.5% | 12.6% | 10.6% | — |
| Capital Expenditure | 320.17M | 287.56M | 223.61M | 228.74M | — |
| Free Cash Flow | 349.97M | 489.96M | 502.13M | 454.59M | — |
| FCF Margin | 7.0% | 9.1% | 8.7% | 7.0% | — |
| FCF Conversion | 146.3% | 160.4% | 152.5% | 122.8% | — |
| EPS (Diluted) | 2.81/sh | 3.59/sh | 3.87/sh | 4.35/sh | 2.81/sh |
| Dividend / Share | 4.13/sh | 1.25/sh | 2.50/sh | 2.50/sh | — |
Dividend return (if you buy today)if you buy today
Dividend yield5.22%
Dividend / share2.50
If you invest
Shares (≈)208
Est. annual income520.96
At this rate, dividends alone return your capital in ~19.2 years.
Dividend history
Dividend / share & historical yield (SAR).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · SAR
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — |
| 2024 | — | — | — | — | 2.50 | — |
| 2023 | — | — | — | — | 2.50 | — |
| 2022 | — | — | — | — | 1.25 | — |
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM، Graham، Residual Income، Earnings Power).
Each method below is a different lens on the same company — no single method dominates the result.
Discounted Cash Flow
Values the company from the future cash it's expected to generate. · Tap to adjust assumptions
99.07
Dividend Discount Model
Values the share from the dividends it's expected to keep paying. · Tap to adjust assumptions
45.54
Graham Number
A conservative benchmark built from earnings and book value. · Tap to adjust assumptions
39.81
Residual Income (justified P/B)
Values the profit the company earns above the cost of its equity. · Tap to adjust assumptions
47.96
Earnings Power Value
Values today's earning power as-is, assuming no growth. · Tap to adjust assumptions
39.15
DCF only is anchored on FY2024 — the latest year with positive cash flow that supports a value. The other methods (DDM, Graham, RIM, EPV) use current / normalized figures.
Fair Value (median)45.54
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 8.67%
- CAPM cost of equity
- 10.50%
- Risk-free rate
- 4.50%
- Equity risk premium
- 6.00%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 5
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in Al-Dawaa Medical Services regularly?
Starting year
Not enough history to simulate.
Community Notes0
No notes yet. Be the first to share a thesis.